HOME >> MEDICINE >> NEWS
Cervical cancer treatment depends on patient age

St. Louis, Dec. 28, 2004 -- Elderly women with cervical cancer face double jeopardy. Not only does their advanced age decrease chances of survival, it also decreases the likelihood that they'll be given the most aggressive treatments for their disease, according to a study by researchers at Washington University School of Medicine in St. Louis.

The study is reported in the Jan. 1, 2005 issue of the journal Cancer.

"The aging of the U.S. population has increased interest in treatments for geriatric cancer patients, but there is very little data about treatment of cervical cancer in the elderly," says first author Jason Wright, M.D., a Washington University gynecological oncologist and part of a team of investigators associated with the Siteman Cancer Center.

A recent report issued by the National Cancer Institute showed that women ages 65 and older die from cervical cancer at a rate of 7.6 per 100,000, compared to 2.1 for women younger than 65.

The Washington University researchers analyzed medical records of more than 1,500 patients treated for invasive cervical cancer at Barnes-Jewish Hospital and the Siteman Cancer Center between 1986 and 2003. They divided the records into two categories, women younger than 70 and women 70 or older.

Their study showed that regardless of the stage of tumor development, elderly patients were likely to receive less aggressive treatment. Surgery was used to treat 16 percent of the elderly group, whereas 54 percent the younger patients underwent surgery. The remainder of the patients were treated with radiation without surgery.

For women treated with radiation therapy alone, the chances of surviving were five times lower than for those treated surgically. Elderly women treated with radiation were given lower doses on average, and they were nine times more likely to forego treatment altogether.

Treatment choices were not the only factors to affect survival; the stage of tumor
'"/>

Contact: Jim Dryden
jdryden@wustl.edu
314-286-0110
Washington University School of Medicine
28-Dec-2004


Page: 1 2

Related medicine news :

1. Cervical cancer A single vaccine could benefit most women
2. Cervical cancer vaccine may lose effectiveness during ovulation
3. Cervical tissue changes may explain false negative pap smears
4. Further Evidence On The Effect Of The UK Cervical Screening Programme
5. Cervical Screening Has Reduced Incidence And Mortality From Cervical Cancer
6. Vinegar Offers Dependable Test For Cervical Cancer
7. Women Who Have Invasive Cervical Cancer Benefit From Addition Of Chemotherapy To Radiation Treatment
8. Hormonal treatment improves survival in high-risk prostate cancer patients
9. International breast cancer prevention study launches in the United States and Canada
10. Unexpected benefit seen in treating HER-2 breast cancer with new preoperative drug combo
11. Cultural and social factors influence prostate cancer treatment

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/13/2017)... SAN LUIS OBISPO, Calif. (PRWEB) , ... October 13, 2017 , ... ... with Alzheimer’s or dementia. However, many long-term care insurance companies have a waiver for ... mean is the 90-day elimination period, when the family pays for care, is often ...
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... Yisrayl Hawkins, ... week that explains one of the most popular and least understood books in the ... cryptic and puzzling descriptions that have baffled scholars for centuries. Many have tossed it ...
(Date:10/13/2017)... ... , ... “America On The Brink”: the Christian history of the United States ... creation of published author, William Nowers. Captain Nowers and his wife, Millie, have ... thirty years in the Navy. Following his career as a naval aviator and ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... ... products to meet the demand of today’s consumer and regulatory authorities worldwide. From ... probiotic experts and tested to meet the highest standard. , These products ...
(Date:10/12/2017)... ... 12, 2017 , ... Information about the technology: , Otomagnetics ... enable prevention of a major side effect of chemotherapy in children. Cisplatin and ... For cisplatin, hearing loss is FDA listed on-label as a dose limiting toxicity. ...
Breaking Medicine News(10 mins):
(Date:10/11/2017)... 11, 2017  True Health, a leader in ... effort during National Breast Cancer Awareness month to ... Research recently ... that more than 10 million American women are ... BRCA1 or BRCA2 and have not had testing. These ...
(Date:10/10/2017)... Oct. 10, 2017  NDS received FDA 510(k) clearance in May ... battery-powered display stand specifically designed for endoscopy environments. An innovative secondary ... a clinical solution to support the improvement of patient outcomes, procedural ... ... ...
(Date:10/7/2017)... --  Provista, a proven leader in the supply ... power, today announced a new resource area on Provistaco.com ... is the online home for case studies, articles on ... releases, slideshows and events. ... at their fingertips, viewers can also watch short videos ...
Breaking Medicine Technology:
Cached News: